NIPTs Pose Moral Quandaries | GenomeWeb

As non-invasive prenatal genetic testing advances more broadly into the marketplace and as tests for more and more disorders, conditions — and eventually, traits — become widely available to pregnant women and couples, some difficult ethical questions are bound to arise, Amanda Schaffer writes at Technology Review.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

A Lab at Home

To Regulate or Not?

Call for More Support

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.